Cosmo Pharmaceuticals N.V Financial Flexibility Index
Cosmo Pharmaceuticals N.V financial flexibility index. Cosmo Pharmaceuticals N.V (C43) has a Financial Flexibility Index of 0.02x as of June 2022. Free cash flow of €7.39 Million (operating CF €6.28 Million minus capex €1.11 Million) represents 0% of total liabilities (€296.03 Million). See cash generation quality of Cosmo Pharmaceuticals N.V to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Cosmo Pharmaceuticals N.V (2016–2025)
Financial flexibility index of Cosmo Pharmaceuticals N.V from 2016 to 2025. Historical Financial Flexibility Index trend for Cosmo Pharmaceuticals N.V across 10 annual periods. Check C43 operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
Cosmo Pharmaceuticals N.V Financial Flexibility Index by Year (2016–2025)
Cosmo Pharmaceuticals N.V financial flexibility index by year from 2016 to 2025. Year-by-year free cash flow to debt coverage for Cosmo Pharmaceuticals N.V. For the full cash flow conversion analysis, see Cosmo Pharmaceuticals N.V cash conversion from operations.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.06x | €-7.02 Million | €-12.48 Million | €123.46 Million | ▼ -104.8% |
| 2024 | 1.19x | €168.06 Million | €162.41 Million | €141.68 Million | ▲ +196.8% |
| 2023 | 0.40x | €48.93 Million | €33.62 Million | €122.42 Million | ▲ +191.7% |
| 2022 | 0.14x | €40.54 Million | €33.23 Million | €295.80 Million | ▲ +121.8% |
| 2021 | 0.06x | €18.10 Million | €12.61 Million | €292.88 Million | ▼ -29.2% |
| 2020 | 0.09x | €17.11 Million | €12.98 Million | €196.04 Million | ▲ +200.6% |
| 2019 | -0.09x | €-16.60 Million | €-18.85 Million | €191.43 Million | ▼ -89.7% |
| 2018 | -0.05x | €-8.27 Million | €-10.16 Million | €180.83 Million | ▼ -144.5% |
| 2017 | 0.10x | €2.86 Million | €-9.43 Million | €27.86 Million | ▼ -92.9% |
| 2016 | 1.44x | €40.12 Million | €21.69 Million | €27.92 Million | — |